1. Pulmonary neuroendocrine cells amplify allergic asthma responses
- Author
-
Sui, Pengfei, Wiesner, Darin L, Xu, Jinhao, Zhang, Yan, Lee, Jinwoo, Van Dyken, Steven, Lashua, Amber, Yu, Chuyue, Klein, Bruce S, Locksley, Richard M, Deutsch, Gail, and Sun, Xin
- Subjects
Lung ,Asthma ,2.1 Biological and endogenous factors ,Aetiology ,Inflammatory and immune system ,Respiratory ,Animals ,Basic Helix-Loop-Helix Transcription Factors ,Calcitonin Gene-Related Peptide ,Cytokines ,Disease Models ,Animal ,Epithelial Cells ,Female ,Goblet Cells ,Humans ,Hyperplasia ,Mice ,Neuroendocrine Cells ,gamma-Aminobutyric Acid ,General Science & Technology - Abstract
Pulmonary neuroendocrine cells (PNECs) are rare airway epithelial cells whose function is poorly understood. Here we show that Ascl1-mutant mice that have no PNECs exhibit severely blunted mucosal type 2 response in models of allergic asthma. PNECs reside in close proximity to group 2 innate lymphoid cells (ILC2s) near airway branch points. PNECs act through calcitonin gene-related peptide (CGRP) to stimulate ILC2s and elicit downstream immune responses. In addition, PNECs act through the neurotransmitter γ-aminobutyric acid (GABA) to induce goblet cell hyperplasia. The instillation of a mixture of CGRP and GABA in Ascl1-mutant airways restores both immune and goblet cell responses. In accordance, lungs from human asthmatics show increased PNECs. These findings demonstrate that the PNEC-ILC2 neuroimmunological modules function at airway branch points to amplify allergic asthma responses.
- Published
- 2018